Navigation Links
Hyperion Therapeutics Elects Lota Zoth to Board of Directors
Date:4/7/2008

SOUTH SAN FRANCISCO, Calif., April 7, 2008 /PRNewswire/ -- Hyperion Therapeutics, Inc., a privately held biopharmaceutical company, today announced that Lota S. Zoth has been elected to the company's Board of Directors. Ms. Zoth formerly served as Senior Vice President and Chief Financial Officer of MedImmune, Inc. with oversight of finance, information technology and public affairs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

In discussing her appointment, Ms. Zoth commented, "Hyperion's co-promotion agreements and strong product pipeline make it a very attractive opportunity. I look forward to helping the Hyperion team continue to execute on its growth objectives."

Prior to MedImmune, Ms. Zoth was Chief Accounting Officer for PSINet, Inc. and Sodexho Marriott Services, Inc., both of which were publicly-held companies. She also served in various finance executive roles at Marriott International and PepsiCo, Inc. after spending almost a decade at Ernst & Young as an audit executive. Ms. Zoth is a certified public accountant and holds a bachelor's of business administration degree in accounting from Texas Tech University.

"Lota's extensive financial and operational background will be a valuable addition to our Board of Directors," said Chris Rivera, President and Chief Executive Officer of Hyperion Therapeutics, Inc. "We look forward to her contributions as we build out our financing strategies with an eye towards accessing the public markets."

About Hyperion Therapeutics

Hyperion Therapeutics is a fully-integrated specialty therapeutics company committed to becoming a global leader in the development and commercialization of hepatology and gastrointestinal therapies that address orphan or underserved patient populations with unmet medical needs. Hyperion's commercial operations division currently markets two products in the United States for urea cycle disorder. The Company is also conducting two phase II trials, one in the chronic treatment of urea cycle disorder and the other in the treatment of acute hepatic encephalopathy. Hyperion is headquartered in South San Francisco, CA. For additional information, visit http://www.hyperiontx.com.


'/>"/>
SOURCE Hyperion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
2. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
3. Antisense therapeutics scientist out to pull more big deals
4. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
5. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
6. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
7. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
8. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
9. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
10. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
11. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill ... local company MitoXcell in preparation of the launch of her new book: Natalie Jill’s ... is a nutritional guide designed to jump start a new healthy lifestyle featuring simple ...
(Date:5/4/2016)... Durham, NC (PRWEB) , ... May 04, 2016 ... ... healthcare professionals in medical coding, billing and compliance. In upcoming months, AudioEducator has ... on various specialties. Every conference is designed to give complete compliance know-how and ...
(Date:5/4/2016)... Los Angeles, California (PRWEB) , ... May 04, 2016 , ... ... for Cancer Research (AACR) honors the month of May as National Cancer Research Month. ... to 1.6 million new diagnoses of cancer with predications of one in four Americans ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... that their Vasont Universal Integrator (VUI) extension supports the latest release of Adobe ... Adobe FrameMaker 2015 interlace the process of creating, editing and storing XML. ...
(Date:5/3/2016)... ... 2016 , ... ProIntro Glitch is a set of 30 self-animating glitch-themed intros ... users to add a terrifying opener to any video or media. Choose from unique ... add greater contrast, all the user has to do is increase the turn on ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... In March, 2016, Rx-360 ... free workshops across Africa ... Good Distribution Practices (GDP). Good Distribution Practice is ... are consistently stored, transported and handled under suitable conditions as ... Only a few years ago, there were few ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
Breaking Medicine Technology: